SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001510964-22-000069
Filing Date
2022-08-15
Accepted
2022-08-15 16:22:16
Documents
67
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cvsi-20220630.htm   iXBRL 10-Q 1295029
2 EX-3.9 certificateofamendment.htm EX-3.9 8613
3 EX-31.1 cvsi-20220630xex311.htm EX-31.1 9348
4 EX-31.2 cvsi-20220630xex312.htm EX-31.2 9324
5 EX-32.1 cvsi-20220630xex321.htm EX-32.1 4279
6 EX-32.2 cvsi-20220630xex322.htm EX-32.2 4248
  Complete submission text file 0001510964-22-000069.txt   6205218

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cvsi-20220630.xsd EX-101.SCH 42327
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cvsi-20220630_cal.xml EX-101.CAL 54299
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cvsi-20220630_def.xml EX-101.DEF 219744
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cvsi-20220630_lab.xml EX-101.LAB 569332
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cvsi-20220630_pre.xml EX-101.PRE 353642
61 EXTRACTED XBRL INSTANCE DOCUMENT cvsi-20220630_htm.xml XML 954540
Mailing Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126
Business Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

IRS No.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54677 | Film No.: 221165940
SIC: 2834 Pharmaceutical Preparations